Cme (CME) Shares Outstanding (Diluted Average) (2009 - 2026)

Cme (CME) has 18 years of Shares Outstanding (Diluted Average) data on file, last reported at $363.2 million in Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) rose 0.83% year-over-year to $363.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $363.2 million (up 0.83% YoY) and the FY2025 annual result came in at $360.3 million, changed 0.1% from the prior year.
• Shares Outstanding (Diluted Average) grew to $363.2 million in Q1 2026 per CME's latest filing, from $360.3 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $363.2 million in Q1 2026 and bottomed at $359.2 million in Q2 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $359.8 million (2024), against an average of $359.9 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) grew 0.04%; it then advanced 0.83% in 2026.
• Tracing CME's Shares Outstanding (Diluted Average) over 5 years: stood at $359.2 million in 2022, then advanced by 0.09% to $359.5 million in 2023, then increased by 0.12% to $359.9 million in 2024, then climbed by 0.1% to $360.3 million in 2025, then rose by 0.8% to $363.2 million in 2026.
• Per Business Quant, the three latest CME Shares Outstanding (Diluted Average) figures stand at $363.2 million (Q1 2026), $360.3 million (Q4 2025), and $360.3 million (Q3 2025).

Peer Comparison